Study links low cerebrospinal fluid proteins with early Parkinson's disease

08/29/2013 | MedPage Today (free registration)

Patients with early-stage Parkinson's disease had lower levels of beta-amyloid protein AB42, total tau protein, P-tau protein and alpha-synuclein in their cerebrospinal fluid than healthy controls, all of which are associated with motor disturbances in Parkinson's disease. The four proteins "have prognostic and diagnostic potential in early-stage Parkinson's disease, [and] suggest biomarker strategies for the possible recognition of prodromal Parkinson's disease," the researchers write in JAMA Neurology.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL